# CHEGG, INC (CHGG) — delisting/forced [announced]
Source: SEC API (secapi.ai) · situation sit_5e38c32bdf74471258c9 · retrieved 2026-08-11T16:13:53.553Z

## Overview
Chegg, Inc. is a global learning and workforce skilling company offering innovative tools for workplace readiness, professional upskilling, language learning, and AI-driven personalized support for students.

On July 24, 2026, Chegg, Inc. received notice from the New York Stock Exchange that it failed to comply with Section 802.01C of the NYSE Listed Company Manual because the average closing share price of its common stock was less than $1.00 over a consecutive 30 trading-day period ending July 23, 2026. The Company has a six-month cure period to regain compliance by achieving a closing share price of at least $1.00 and an average closing share price of at least $1.00 over a 30 trading-day period ending on the last trading day of any calendar month during the cure period. The Company intends to notify the NYSE of its intent to regain compliance, which may include effecting a reverse stock split subject to board approval. If the Company fails to regain compliance within the cure period, its common stock will be subject to NYSE suspension and delisting procedures.

## Terms
- Counterparty: New York Stock Exchange · Price/share: $1

## Key dates
- Announced 2026-07-24 · Expiry 2027-01-24

## Timeline
- 2026-07-24 · 8-K (0001364954-26-000082): 8-K - CHEGG, INC — *Chegg, Inc. is a global learning and workforce skilling company offering innovative tools for workplace readiness, professional upskilling, language learning, and AI-driven personalized support for students.* On July 24, 2026, Chegg, Inc. received notice from the New York Stock Exchange that it failed to comply with Section 802.01C of the NYSE Listed Company Manual because the average closing share price of its common stock was less than $1.00 over a consecutive 30 trading-day period ending July 23, 2026. The Company has a six-month cure period to regain compliance by achieving a closing share price of at least $1.00 and an average closing share price of at least $1.00 over a 30 trading-day period ending on the last trading day of any calendar month during the cure period. The Company intends to notify the NYSE of its intent to regain compliance, which may include effecting a reverse stock split subject to board approval. If the Company fails to regain compliance within the cure period, its common stock will be subject to NYSE suspension and delisting procedures.
  https://www.sec.gov/Archives/edgar/data/1364954/0001364954-26-000082.txt

## Citations
- 0001364954-26-000082 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000136495426000082